GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) » Definitions » EBITDA Margin %

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) EBITDA Margin % : 9.63% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is JSP Pharmaceutical Manufacturing (Thailand) PCL EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. JSP Pharmaceutical Manufacturing (Thailand) PCL's EBITDA for the three months ended in Mar. 2024 was ฿14.98 Mil. JSP Pharmaceutical Manufacturing (Thailand) PCL's Revenue for the three months ended in Mar. 2024 was ฿155.66 Mil. Therefore, JSP Pharmaceutical Manufacturing (Thailand) PCL's EBITDA margin for the quarter that ended in Mar. 2024 was 9.63%.


JSP Pharmaceutical Manufacturing (Thailand) PCL EBITDA Margin % Historical Data

The historical data trend for JSP Pharmaceutical Manufacturing (Thailand) PCL's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JSP Pharmaceutical Manufacturing (Thailand) PCL EBITDA Margin % Chart

JSP Pharmaceutical Manufacturing (Thailand) PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
16.36 16.06 16.59 7.58 16.90

JSP Pharmaceutical Manufacturing (Thailand) PCL Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.47 -2.68 35.79 14.95 9.63

Competitive Comparison of JSP Pharmaceutical Manufacturing (Thailand) PCL's EBITDA Margin %

For the Packaged Foods subindustry, JSP Pharmaceutical Manufacturing (Thailand) PCL's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JSP Pharmaceutical Manufacturing (Thailand) PCL's EBITDA Margin % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, JSP Pharmaceutical Manufacturing (Thailand) PCL's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where JSP Pharmaceutical Manufacturing (Thailand) PCL's EBITDA Margin % falls into.



JSP Pharmaceutical Manufacturing (Thailand) PCL EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

JSP Pharmaceutical Manufacturing (Thailand) PCL's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=97.263/575.578
=16.90 %

JSP Pharmaceutical Manufacturing (Thailand) PCL's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=14.984/155.661
=9.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


JSP Pharmaceutical Manufacturing (Thailand) PCL  (BKK:JSP-F) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


JSP Pharmaceutical Manufacturing (Thailand) PCL EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of JSP Pharmaceutical Manufacturing (Thailand) PCL's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Business Description

Traded in Other Exchanges
N/A
Address
No. 255 and 257, Soi Sathupradit, 58, Bang Pongphang, Yannawa, Bangkok, THA, 10120
JSP Pharmaceutical Manufacturing (Thailand) PCL is engaged in producing drugs, dietary supplements, cosmetics, herbs, and dietary supplements in the form of vitamins including healthy coffee Ready. Its segments include Manufacturing and distribution of products under the customer's Brand name and Own Brand name. The majority of the revenue comes from the manufacturing and distribution of products under the customer's brand name. The Group is managed and operates principally in Thailand.

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Headlines

No Headlines